

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 9.12173942 |
| 2 | regulation of water loss via skin (GO:0033561) | 8.54686447 |
| 3 | establishment of skin barrier (GO:0061436) | 8.53351215 |
| 4 | response to methylmercury (GO:0051597) | 8.20494403 |
| 5 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.94487486 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.82653022 |
| 7 | regulation of lipoprotein metabolic process (GO:0050746) | 6.43414605 |
| 8 | cholesterol biosynthetic process (GO:0006695) | 6.39501155 |
| 9 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 6.17725012 |
| 10 | myelin maintenance (GO:0043217) | 6.10922465 |
| 11 | skin morphogenesis (GO:0043589) | 6.05576499 |
| 12 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.96421422 |
| 13 | multicellular organismal water homeostasis (GO:0050891) | 5.85828063 |
| 14 | sterol biosynthetic process (GO:0016126) | 5.82123576 |
| 15 | hemidesmosome assembly (GO:0031581) | 5.74105780 |
| 16 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.48098621 |
| 17 | negative regulation of protein localization to cell surface (GO:2000009) | 5.26977892 |
| 18 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.23897838 |
| 19 | * ensheathment of neurons (GO:0007272) | 5.22226334 |
| 20 | * axon ensheathment (GO:0008366) | 5.22226334 |
| 21 | * myelination (GO:0042552) | 5.21205506 |
| 22 | astrocyte differentiation (GO:0048708) | 5.05424724 |
| 23 | establishment of mitochondrion localization (GO:0051654) | 4.99253384 |
| 24 | water homeostasis (GO:0030104) | 4.92342714 |
| 25 | negative regulation of neurotransmitter transport (GO:0051589) | 4.90664617 |
| 26 | very long-chain fatty acid metabolic process (GO:0000038) | 4.86928807 |
| 27 | keratinocyte proliferation (GO:0043616) | 4.79348162 |
| 28 | keratinocyte differentiation (GO:0030216) | 4.72211711 |
| 29 | isoprenoid biosynthetic process (GO:0008299) | 4.70165909 |
| 30 | regulation of collateral sprouting (GO:0048670) | 4.67126286 |
| 31 | protein retention in ER lumen (GO:0006621) | 4.62066437 |
| 32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.60247686 |
| 33 | activation of Rac GTPase activity (GO:0032863) | 4.50056281 |
| 34 | amyloid precursor protein catabolic process (GO:0042987) | 4.47070628 |
| 35 | L-amino acid import (GO:0043092) | 4.45709658 |
| 36 | proteasome assembly (GO:0043248) | 4.45252261 |
| 37 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 4.39967308 |
| 38 | thioester biosynthetic process (GO:0035384) | 4.39468426 |
| 39 | acyl-CoA biosynthetic process (GO:0071616) | 4.39468426 |
| 40 | * amyloid precursor protein metabolic process (GO:0042982) | 4.33472604 |
| 41 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.30023757 |
| 42 | gap junction assembly (GO:0016264) | 4.25602743 |
| 43 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.15100482 |
| 44 | epidermis development (GO:0008544) | 4.07545562 |
| 45 | epidermal cell differentiation (GO:0009913) | 4.00482342 |
| 46 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.94259485 |
| 47 | extracellular matrix assembly (GO:0085029) | 3.92673395 |
| 48 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.91462957 |
| 49 | creatine metabolic process (GO:0006600) | 3.90865564 |
| 50 | regulation of phospholipase A2 activity (GO:0032429) | 3.90687728 |
| 51 | response to lipoprotein particle (GO:0055094) | 3.87161913 |
| 52 | membrane tubulation (GO:0097320) | 3.86002979 |
| 53 | peptide cross-linking (GO:0018149) | 3.82254008 |
| 54 | hepatocyte apoptotic process (GO:0097284) | 3.78753414 |
| 55 | L-serine transport (GO:0015825) | 3.76974105 |
| 56 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.75356381 |
| 57 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.65297338 |
| 58 | import into cell (GO:0098657) | 3.63124111 |
| 59 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.60101551 |
| 60 | membrane budding (GO:0006900) | 3.59471030 |
| 61 | neurotransmitter uptake (GO:0001504) | 3.56451636 |
| 62 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.53788056 |
| 63 | protein neddylation (GO:0045116) | 3.52487479 |
| 64 | magnesium ion transport (GO:0015693) | 3.51259530 |
| 65 | regulation of mitotic spindle organization (GO:0060236) | 3.49985373 |
| 66 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.47768675 |
| 67 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.47443385 |
| 68 | prostaglandin biosynthetic process (GO:0001516) | 3.43199720 |
| 69 | prostanoid biosynthetic process (GO:0046457) | 3.43199720 |
| 70 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.40927718 |
| 71 | axon development (GO:0061564) | 3.40195749 |
| 72 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.39527004 |
| 73 | heme transport (GO:0015886) | 3.38295760 |
| 74 | molting cycle (GO:0042303) | 3.37428830 |
| 75 | hair cycle (GO:0042633) | 3.37428830 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.36884827 |
| 77 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.33295154 |
| 78 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.33160086 |
| 79 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.33056645 |
| 80 | establishment of protein localization to plasma membrane (GO:0090002) | 3.31069202 |
| 81 | positive regulation of epidermis development (GO:0045684) | 3.30771277 |
| 82 | membrane raft organization (GO:0031579) | 3.30433228 |
| 83 | glycerophospholipid catabolic process (GO:0046475) | 3.29488486 |
| 84 | ether lipid metabolic process (GO:0046485) | 3.23629742 |
| 85 | coenzyme catabolic process (GO:0009109) | 3.22708713 |
| 86 | protein prenylation (GO:0018342) | 3.22225140 |
| 87 | prenylation (GO:0097354) | 3.22225140 |
| 88 | substantia nigra development (GO:0021762) | 3.19796191 |
| 89 | negative regulation of chemokine production (GO:0032682) | 3.19234352 |
| 90 | amino acid import (GO:0043090) | 3.18867133 |
| 91 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.18761743 |
| 92 | iron coordination entity transport (GO:1901678) | 3.16817466 |
| 93 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.16288315 |
| 94 | glycosylceramide metabolic process (GO:0006677) | 3.15140373 |
| 95 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.14516563 |
| 96 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.13245521 |
| 97 | serine transport (GO:0032329) | 3.12621422 |
| 98 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.12413881 |
| 99 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.12413881 |
| 100 | eye photoreceptor cell differentiation (GO:0001754) | 3.07468493 |
| 101 | photoreceptor cell differentiation (GO:0046530) | 3.07468493 |
| 102 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.04735575 |
| 103 | cell-substrate junction assembly (GO:0007044) | 3.04565643 |
| 104 | alcohol biosynthetic process (GO:0046165) | 3.03149474 |
| 105 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.02335878 |
| 106 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.02043933 |
| 107 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.02043933 |
| 108 | keratinocyte development (GO:0003334) | 3.00437969 |
| 109 | response to redox state (GO:0051775) | 2.99576020 |
| 110 | protein palmitoylation (GO:0018345) | 2.99542650 |
| 111 | regulation of spindle organization (GO:0090224) | 2.99061559 |
| 112 | negative regulation of adherens junction organization (GO:1903392) | 2.97617655 |
| 113 | negative regulation of focal adhesion assembly (GO:0051895) | 2.97617655 |
| 114 | negative regulation of cell junction assembly (GO:1901889) | 2.97617655 |
| 115 | thioester metabolic process (GO:0035383) | 2.97458750 |
| 116 | acyl-CoA metabolic process (GO:0006637) | 2.97458750 |
| 117 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.96673523 |
| 118 | ectoderm development (GO:0007398) | 2.96313719 |
| 119 | triglyceride biosynthetic process (GO:0019432) | 2.95918482 |
| 120 | cofactor catabolic process (GO:0051187) | 2.95523632 |
| 121 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.93597655 |
| 122 | sodium ion export (GO:0071436) | 2.92251260 |
| 123 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.92109954 |
| 124 | keratinization (GO:0031424) | 2.90427218 |
| 125 | neuron remodeling (GO:0016322) | 2.89579846 |
| 126 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.88328574 |
| 127 | nucleoside salvage (GO:0043174) | 2.88097859 |
| 128 | * positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.87376456 |
| 129 | negative regulation of ligase activity (GO:0051352) | 2.87152428 |
| 130 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.87152428 |
| 131 | cell communication involved in cardiac conduction (GO:0086065) | 2.84705670 |
| 132 | cholesterol metabolic process (GO:0008203) | 2.83245329 |
| 133 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.82107345 |
| 134 | glycine transport (GO:0015816) | 2.81418489 |
| 135 | regulation of G0 to G1 transition (GO:0070316) | 2.81072844 |
| 136 | cell-cell junction assembly (GO:0007043) | 2.80142822 |
| 137 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.80096033 |
| 138 | regulation of cardioblast differentiation (GO:0051890) | 2.80047467 |
| 139 | Golgi transport vesicle coating (GO:0048200) | 2.79187445 |
| 140 | COPI coating of Golgi vesicle (GO:0048205) | 2.79187445 |
| 141 | astrocyte development (GO:0014002) | 2.79048837 |
| 142 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78728439 |
| 143 | regulation of hair cycle (GO:0042634) | 2.78416668 |
| 144 | neutral lipid biosynthetic process (GO:0046460) | 2.78382508 |
| 145 | acylglycerol biosynthetic process (GO:0046463) | 2.78382508 |
| 146 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.77977076 |
| 147 | GPI anchor biosynthetic process (GO:0006506) | 2.77849911 |
| 148 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.76172282 |
| 149 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.75896665 |
| 150 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.75896665 |
| 151 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.73227181 |
| 152 | regulation of keratinocyte proliferation (GO:0010837) | 2.72499497 |
| 153 | regulation of cellular amine metabolic process (GO:0033238) | 2.71850838 |
| 154 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.70655721 |
| 155 | glutamate secretion (GO:0014047) | 2.70379397 |
| 156 | focal adhesion assembly (GO:0048041) | 2.70311989 |
| 157 | cell-substrate adherens junction assembly (GO:0007045) | 2.70311989 |
| 158 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.67596343 |
| 159 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.67596343 |
| 160 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.67596343 |
| 161 | intermediate filament cytoskeleton organization (GO:0045104) | 2.66686996 |
| 162 | estrogen biosynthetic process (GO:0006703) | 2.66040246 |
| 163 | negative regulation of axonogenesis (GO:0050771) | 2.65971011 |
| 164 | GPI anchor metabolic process (GO:0006505) | 2.65597367 |
| 165 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.64832167 |
| 166 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.63427998 |
| 167 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.63427998 |
| 168 | fatty acid biosynthetic process (GO:0006633) | 2.62985403 |
| 169 | sterol metabolic process (GO:0016125) | 2.62485524 |
| 170 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.62254545 |
| 171 | nerve growth factor signaling pathway (GO:0038180) | 2.61986349 |
| 172 | citrulline biosynthetic process (GO:0019240) | 2.60915846 |
| 173 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.60765668 |
| 174 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.60588201 |
| 175 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.59999425 |
| 176 | apical protein localization (GO:0045176) | 2.59985034 |
| 177 | regulation of exit from mitosis (GO:0007096) | 2.59906586 |
| 178 | negative regulation of cell fate specification (GO:0009996) | 2.59239989 |
| 179 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.59097775 |
| 180 | pyrimidine nucleoside salvage (GO:0043097) | 2.58496164 |
| 181 | protein localization to endosome (GO:0036010) | 2.57281957 |
| 182 | cellular response to cholesterol (GO:0071397) | 2.56849587 |
| 183 | response to dietary excess (GO:0002021) | 2.56447098 |
| 184 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.55170319 |
| 185 | asymmetric protein localization (GO:0008105) | 2.53710508 |
| 186 | phosphatidylserine metabolic process (GO:0006658) | 2.53189115 |
| 187 | organ growth (GO:0035265) | 2.52786157 |
| 188 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.52731437 |
| 189 | central nervous system myelination (GO:0022010) | 12.0330727 |
| 190 | axon ensheathment in central nervous system (GO:0032291) | 12.0330727 |
| 191 | fatty acid elongation (GO:0030497) | 11.0318536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.95942174 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.17091480 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.04312371 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.70515892 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.68286932 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.54103128 |
| 7 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.46296989 |
| 8 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.45847241 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45006549 |
| 10 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.34849296 |
| 11 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.32874871 |
| 12 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.32874871 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31182810 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.31020033 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.28015769 |
| 16 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.21309967 |
| 17 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.19291044 |
| 18 | ATF3_27146783_Chip-Seq_COLON_Human | 2.16501398 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03594465 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.02385528 |
| 21 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.96575311 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.92768231 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.90710589 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86650326 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86573055 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84365641 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80520062 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.77820922 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77271198 |
| 30 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.74835699 |
| 31 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.74346335 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72500722 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71086465 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70928153 |
| 35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70920444 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.69543116 |
| 37 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.69416415 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.61605306 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.60790867 |
| 40 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.60690280 |
| 41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.60514571 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60479322 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60300857 |
| 44 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.60262984 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59573671 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55211661 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.53691613 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53466001 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53466001 |
| 50 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.53381217 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52745884 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.52454914 |
| 53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.52427449 |
| 54 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51961547 |
| 55 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50140267 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48449836 |
| 57 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.47581377 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47156295 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45201194 |
| 60 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.44866981 |
| 61 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.44273780 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43098235 |
| 63 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.42473866 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41679030 |
| 65 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.39997918 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.39997918 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39331591 |
| 68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37527449 |
| 69 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.36968514 |
| 70 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.34651939 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.34521600 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33942969 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32979060 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32268919 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30978980 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.30268287 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30213223 |
| 78 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30208744 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.30080223 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27564383 |
| 81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26927971 |
| 82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26286987 |
| 83 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25034077 |
| 84 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24796813 |
| 85 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.24321188 |
| 86 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23648956 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23583570 |
| 88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23459076 |
| 89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23421256 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22591161 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21582902 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21092235 |
| 93 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.19468302 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18998237 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 1.18337573 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17460240 |
| 97 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.17077443 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16220136 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16185838 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16089401 |
| 101 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.16041296 |
| 102 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.15843543 |
| 103 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14374509 |
| 104 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14021532 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13397312 |
| 106 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13207013 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11179001 |
| 108 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.10702692 |
| 109 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.09096010 |
| 110 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.09096010 |
| 111 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.09096010 |
| 112 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08412224 |
| 113 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08354824 |
| 114 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08008250 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07709627 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07285420 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06223446 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05359180 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04740466 |
| 120 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04644966 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04624147 |
| 122 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02890411 |
| 123 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02701863 |
| 124 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02701863 |
| 125 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02642948 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02546079 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.01139816 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00718896 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.99769491 |
| 130 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99038696 |
| 131 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98954685 |
| 132 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98879559 |
| 133 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98873931 |
| 134 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98146189 |
| 135 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97839634 |
| 136 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97779699 |
| 137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97605188 |
| 138 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97515873 |
| 139 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96980289 |
| 140 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96852645 |
| 141 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96223712 |
| 142 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96211516 |
| 143 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96167702 |
| 144 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95563146 |
| 145 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95521861 |
| 146 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94495509 |
| 147 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94252856 |
| 148 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94151237 |
| 149 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93722633 |
| 150 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93395896 |
| 151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93211388 |
| 152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92649776 |
| 153 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92137129 |
| 154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92087375 |
| 155 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.91990324 |
| 156 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91803725 |
| 157 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90776979 |
| 158 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90117834 |
| 159 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90049314 |
| 160 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.89902683 |
| 161 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89633085 |
| 162 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89452205 |
| 163 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89291633 |
| 164 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.88673911 |
| 165 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88077964 |
| 166 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87893289 |
| 167 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.87793631 |
| 168 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87774765 |
| 169 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.87692170 |
| 170 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87590143 |
| 171 | SA1_27219007_Chip-Seq_Bcells_Human | 0.87503837 |
| 172 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86453528 |
| 173 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86279656 |
| 174 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86096367 |
| 175 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85806340 |
| 176 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85765485 |
| 177 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85112380 |
| 178 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84502709 |
| 179 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84247386 |
| 180 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84184070 |
| 181 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84177584 |
| 182 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83641669 |
| 183 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.83225756 |
| 184 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82933590 |
| 185 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82577248 |
| 186 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81786576 |
| 187 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81500771 |
| 188 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81317962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.68909020 |
| 2 | MP0000920_abnormal_myelination | 5.32575980 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.55316466 |
| 4 | MP0003329_amyloid_beta_deposits | 3.32767573 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 3.31385001 |
| 6 | MP0003878_abnormal_ear_physiology | 3.31385001 |
| 7 | MP0000579_abnormal_nail_morphology | 3.25227923 |
| 8 | MP0003690_abnormal_glial_cell | 3.17166318 |
| 9 | MP0010678_abnormal_skin_adnexa | 3.02825188 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 3.02703099 |
| 11 | MP0000383_abnormal_hair_follicle | 2.85384603 |
| 12 | MP0003880_abnormal_central_pattern | 2.83971398 |
| 13 | MP0001529_abnormal_vocalization | 2.53600734 |
| 14 | MP0002060_abnormal_skin_morphology | 2.48069187 |
| 15 | MP0005409_darkened_coat_color | 2.46160645 |
| 16 | MP0003941_abnormal_skin_development | 2.44908855 |
| 17 | MP0004885_abnormal_endolymph | 2.44417799 |
| 18 | MP0001905_abnormal_dopamine_level | 2.43625011 |
| 19 | MP0004270_analgesia | 2.37900779 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 2.32756204 |
| 21 | MP0008260_abnormal_autophagy | 2.30193555 |
| 22 | MP0004742_abnormal_vestibular_system | 2.24586448 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.23280763 |
| 24 | MP0002796_impaired_skin_barrier | 2.20278180 |
| 25 | MP0003634_abnormal_glial_cell | 2.13635263 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 2.11702409 |
| 27 | MP0003633_abnormal_nervous_system | 2.08806204 |
| 28 | MP0002272_abnormal_nervous_system | 2.07148364 |
| 29 | MP0005171_absent_coat_pigmentation | 2.05621557 |
| 30 | MP0000604_amyloidosis | 2.05398557 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 2.00041828 |
| 32 | MP0003631_nervous_system_phenotype | 1.97919894 |
| 33 | MP0003632_abnormal_nervous_system | 1.94425237 |
| 34 | MP0000537_abnormal_urethra_morphology | 1.92988837 |
| 35 | MP0004142_abnormal_muscle_tone | 1.92256361 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.88773103 |
| 37 | MP0000647_abnormal_sebaceous_gland | 1.84886279 |
| 38 | MP0005410_abnormal_fertilization | 1.82699748 |
| 39 | MP0001486_abnormal_startle_reflex | 1.81392902 |
| 40 | MP0005023_abnormal_wound_healing | 1.80473450 |
| 41 | MP0002064_seizures | 1.75309280 |
| 42 | MP0004043_abnormal_pH_regulation | 1.67774576 |
| 43 | MP0000467_abnormal_esophagus_morphology | 1.66983841 |
| 44 | MP0004381_abnormal_hair_follicle | 1.64434277 |
| 45 | MP0005501_abnormal_skin_physiology | 1.63236486 |
| 46 | MP0004134_abnormal_chest_morphology | 1.57430521 |
| 47 | MP0000778_abnormal_nervous_system | 1.57150375 |
| 48 | MP0003195_calcinosis | 1.54481301 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.53425253 |
| 50 | MP0000462_abnormal_digestive_system | 1.52190220 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.50687914 |
| 52 | MP0002229_neurodegeneration | 1.50186244 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.49016537 |
| 54 | MP0000762_abnormal_tongue_morphology | 1.45976144 |
| 55 | MP0005275_abnormal_skin_tensile | 1.42465686 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 1.41874204 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.40096770 |
| 58 | MP0002877_abnormal_melanocyte_morpholog | 1.37737790 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37662287 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.35949798 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.34746278 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.33054568 |
| 63 | MP0004947_skin_inflammation | 1.30869396 |
| 64 | MP0002295_abnormal_pulmonary_circulatio | 1.30531698 |
| 65 | MP0009697_abnormal_copulation | 1.30176306 |
| 66 | MP0010030_abnormal_orbit_morphology | 1.27498363 |
| 67 | MP0001970_abnormal_pain_threshold | 1.24948482 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.22931042 |
| 69 | MP0000747_muscle_weakness | 1.20413812 |
| 70 | MP0009931_abnormal_skin_appearance | 1.19043140 |
| 71 | MP0000627_abnormal_mammary_gland | 1.18558909 |
| 72 | MP0010771_integument_phenotype | 1.18445747 |
| 73 | MP0008569_lethality_at_weaning | 1.16262306 |
| 74 | MP0001851_eye_inflammation | 1.14728329 |
| 75 | MP0001849_ear_inflammation | 1.14603493 |
| 76 | MP0009053_abnormal_anal_canal | 1.13587841 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.09287582 |
| 78 | MP0003635_abnormal_synaptic_transmissio | 1.07714047 |
| 79 | MP0001177_atelectasis | 1.05816916 |
| 80 | MP0001191_abnormal_skin_condition | 1.05567611 |
| 81 | MP0002063_abnormal_learning/memory/cond | 1.03704529 |
| 82 | MP0004859_abnormal_synaptic_plasticity | 1.03422539 |
| 83 | MP0009745_abnormal_behavioral_response | 1.03338488 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 1.03236414 |
| 85 | MP0005451_abnormal_body_composition | 1.02243377 |
| 86 | MP0004036_abnormal_muscle_relaxation | 1.00798350 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 1.00425952 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 1.00052908 |
| 89 | MP0003315_abnormal_perineum_morphology | 0.99050126 |
| 90 | MP0000367_abnormal_coat/_hair | 0.98607634 |
| 91 | MP0002066_abnormal_motor_capabilities/c | 0.96875899 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.96627695 |
| 93 | MP0000955_abnormal_spinal_cord | 0.95325003 |
| 94 | MP0003075_altered_response_to | 0.94468213 |
| 95 | MP0003136_yellow_coat_color | 0.94098649 |
| 96 | MP0000749_muscle_degeneration | 0.92375351 |
| 97 | MP0002882_abnormal_neuron_morphology | 0.92190933 |
| 98 | MP0000377_abnormal_hair_follicle | 0.92152726 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.91762876 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 0.91627237 |
| 101 | MP0009840_abnormal_foam_cell | 0.91242752 |
| 102 | MP0000858_altered_metastatic_potential | 0.89295435 |
| 103 | MP0005388_respiratory_system_phenotype | 0.85576727 |
| 104 | MP0002133_abnormal_respiratory_system | 0.85576727 |
| 105 | MP0000427_abnormal_hair_cycle | 0.85389862 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.83081291 |
| 107 | MP0001340_abnormal_eyelid_morphology | 0.82785881 |
| 108 | MP0001440_abnormal_grooming_behavior | 0.81077220 |
| 109 | MP0005195_abnormal_posterior_eye | 0.79925119 |
| 110 | MP0006054_spinal_hemorrhage | 0.78499737 |
| 111 | MP0009046_muscle_twitch | 0.78161322 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.77897715 |
| 113 | MP0004858_abnormal_nervous_system | 0.77249151 |
| 114 | MP0001346_abnormal_lacrimal_gland | 0.76781338 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.76617531 |
| 116 | MP0003693_abnormal_embryo_hatching | 0.76059257 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.73718203 |
| 118 | MP0000566_synostosis | 0.73545915 |
| 119 | MP0004233_abnormal_muscle_weight | 0.72094853 |
| 120 | MP0002067_abnormal_sensory_capabilities | 0.71238349 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.71175289 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.71155796 |
| 123 | MP0003011_delayed_dark_adaptation | 0.70919651 |
| 124 | MP0003186_abnormal_redox_activity | 0.68994158 |
| 125 | MP0006082_CNS_inflammation | 0.68838869 |
| 126 | MP0001243_abnormal_dermal_layer | 0.68755296 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.68751430 |
| 128 | MP0004272_abnormal_basement_membrane | 0.67294192 |
| 129 | MP0009250_abnormal_appendicular_skeleto | 0.67197667 |
| 130 | MP0004957_abnormal_blastocyst_morpholog | 0.66920703 |
| 131 | MP0004145_abnormal_muscle_electrophysio | 0.65711249 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.65636449 |
| 133 | MP0001963_abnormal_hearing_physiology | 0.65536699 |
| 134 | MP0002752_abnormal_somatic_nervous | 0.65328495 |
| 135 | MP0003938_abnormal_ear_development | 0.60834840 |
| 136 | MP0002933_joint_inflammation | 0.60021248 |
| 137 | MP0002249_abnormal_larynx_morphology | 0.58821753 |
| 138 | MP0003191_abnormal_cellular_cholesterol | 0.58430590 |
| 139 | MP0002736_abnormal_nociception_after | 0.58198175 |
| 140 | MP0008932_abnormal_embryonic_tissue | 0.58149795 |
| 141 | MP0002090_abnormal_vision | 0.57687970 |
| 142 | MP0002111_abnormal_tail_morphology | 0.50466970 |
| 143 | MP0003786_premature_aging | 0.50442309 |
| 144 | MP0000516_abnormal_urinary_system | 0.50156337 |
| 145 | MP0005367_renal/urinary_system_phenotyp | 0.50156337 |
| 146 | MP0009672_abnormal_birth_weight | 0.49045680 |
| 147 | MP0005621_abnormal_cell_physiology | 0.48023889 |
| 148 | MP0005257_abnormal_intraocular_pressure | 0.47913894 |
| 149 | MP0001348_abnormal_lacrimal_gland | 0.47756261 |
| 150 | MP0001502_abnormal_circadian_rhythm | 0.47449107 |
| 151 | MP0003879_abnormal_hair_cell | 0.46070164 |
| 152 | MP0000358_abnormal_cell_content/ | 0.45937489 |
| 153 | MP0001881_abnormal_mammary_gland | 0.45820349 |
| 154 | MP0001853_heart_inflammation | 0.43776344 |
| 155 | MP0000613_abnormal_salivary_gland | 0.43058892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.65336919 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.65336919 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.46566106 |
| 4 | Onycholysis (HP:0001806) | 6.26916623 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 5.57089164 |
| 6 | Termporal pattern (HP:0011008) | 5.29432345 |
| 7 | Insidious onset (HP:0003587) | 5.29432345 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 5.08777048 |
| 9 | Alopecia of scalp (HP:0002293) | 4.97942543 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.91835157 |
| 11 | Parakeratosis (HP:0001036) | 4.83953384 |
| 12 | Hypotrichosis (HP:0001006) | 4.82481607 |
| 13 | Plantar hyperkeratosis (HP:0007556) | 4.57432014 |
| 14 | Pili torti (HP:0003777) | 4.50860861 |
| 15 | Onion bulb formation (HP:0003383) | 4.25161893 |
| 16 | Palmoplantar hyperkeratosis (HP:0000972) | 4.15407791 |
| 17 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.12111470 |
| 18 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.92854303 |
| 19 | Peripheral hypomyelination (HP:0007182) | 3.90800416 |
| 20 | Palmar hyperkeratosis (HP:0010765) | 3.83997246 |
| 21 | Nail dystrophy (HP:0008404) | 3.77635773 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.75202947 |
| 23 | Ankle clonus (HP:0011448) | 3.74660865 |
| 24 | Abnormality of glycolysis (HP:0004366) | 3.72567612 |
| 25 | Increased serum pyruvate (HP:0003542) | 3.72567612 |
| 26 | Hypokinesia (HP:0002375) | 3.55671012 |
| 27 | Selective tooth agenesis (HP:0001592) | 3.51923975 |
| 28 | Axonal loss (HP:0003447) | 3.51337687 |
| 29 | Sparse eyelashes (HP:0000653) | 3.47998161 |
| 30 | Cerebral hypomyelination (HP:0006808) | 3.47153215 |
| 31 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.45723570 |
| 32 | Retinal dysplasia (HP:0007973) | 3.45274599 |
| 33 | Abnormal hair laboratory examination (HP:0003328) | 3.43124771 |
| 34 | Corneal erosion (HP:0200020) | 3.41612943 |
| 35 | Distal lower limb amyotrophy (HP:0008944) | 3.32353511 |
| 36 | Leukodystrophy (HP:0002415) | 3.24490922 |
| 37 | Trismus (HP:0000211) | 3.21514348 |
| 38 | Erythema (HP:0010783) | 3.20322328 |
| 39 | Truncus arteriosus (HP:0001660) | 3.12211018 |
| 40 | Slow saccadic eye movements (HP:0000514) | 3.09084171 |
| 41 | Hypophosphatemic rickets (HP:0004912) | 3.08613895 |
| 42 | Oral leukoplakia (HP:0002745) | 3.07808395 |
| 43 | Woolly hair (HP:0002224) | 3.03643570 |
| 44 | Increased IgE level (HP:0003212) | 3.02479241 |
| 45 | Milia (HP:0001056) | 3.02248791 |
| 46 | Spastic gait (HP:0002064) | 2.99352454 |
| 47 | Intention tremor (HP:0002080) | 2.98763659 |
| 48 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.97921929 |
| 49 | Dysmetria (HP:0001310) | 2.93816329 |
| 50 | Abnormal large intestine physiology (HP:0012700) | 2.92993020 |
| 51 | Lower limb amyotrophy (HP:0007210) | 2.83572314 |
| 52 | Hyperthyroidism (HP:0000836) | 2.81811566 |
| 53 | Abnormal blistering of the skin (HP:0008066) | 2.70126011 |
| 54 | Ridged nail (HP:0001807) | 2.69998760 |
| 55 | Scanning speech (HP:0002168) | 2.68849455 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.67169609 |
| 57 | Upper limb amyotrophy (HP:0009129) | 2.67169609 |
| 58 | Micronodular cirrhosis (HP:0001413) | 2.66570433 |
| 59 | Action tremor (HP:0002345) | 2.62429478 |
| 60 | Abnormality of nail color (HP:0100643) | 2.59945604 |
| 61 | Spastic tetraparesis (HP:0001285) | 2.59537628 |
| 62 | Abnormal auditory evoked potentials (HP:0006958) | 2.58354200 |
| 63 | Abnormality of the salivary glands (HP:0010286) | 2.56535184 |
| 64 | Cerebral hemorrhage (HP:0001342) | 2.55670710 |
| 65 | Absent eyelashes (HP:0000561) | 2.53713227 |
| 66 | Sensory axonal neuropathy (HP:0003390) | 2.52799211 |
| 67 | Abnormality of placental membranes (HP:0011409) | 2.52014966 |
| 68 | Amniotic constriction ring (HP:0009775) | 2.52014966 |
| 69 | Pustule (HP:0200039) | 2.51482363 |
| 70 | Ankyloglossia (HP:0010296) | 2.48713139 |
| 71 | Palmoplantar keratoderma (HP:0000982) | 2.48421979 |
| 72 | Stridor (HP:0010307) | 2.48343245 |
| 73 | Erythroderma (HP:0001019) | 2.47371375 |
| 74 | Anteriorly placed anus (HP:0001545) | 2.42428343 |
| 75 | CNS hypomyelination (HP:0003429) | 2.40740242 |
| 76 | Urinary urgency (HP:0000012) | 2.39037573 |
| 77 | Ectropion (HP:0000656) | 2.37822119 |
| 78 | Pheochromocytoma (HP:0002666) | 2.34441066 |
| 79 | Increased circulating renin level (HP:0000848) | 2.32250797 |
| 80 | Hammertoe (HP:0001765) | 2.31920286 |
| 81 | Enlarged epiphyses (HP:0010580) | 2.30170188 |
| 82 | Clonus (HP:0002169) | 2.29677647 |
| 83 | Pterygium (HP:0001059) | 2.27104780 |
| 84 | Morphological abnormality of the inner ear (HP:0011390) | 2.26293229 |
| 85 | Hypoplasia of the iris (HP:0007676) | 2.25962564 |
| 86 | Hypohidrosis (HP:0000966) | 2.25046902 |
| 87 | Difficulty walking (HP:0002355) | 2.24776496 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 2.21380874 |
| 89 | Foot dorsiflexor weakness (HP:0009027) | 2.20701720 |
| 90 | Thick nail (HP:0001805) | 2.20647913 |
| 91 | Acute encephalopathy (HP:0006846) | 2.19286664 |
| 92 | Hypoplastic labia majora (HP:0000059) | 2.18388037 |
| 93 | Amelogenesis imperfecta (HP:0000705) | 2.17971907 |
| 94 | Acanthosis nigricans (HP:0000956) | 2.17917993 |
| 95 | Atrophic scars (HP:0001075) | 2.17619049 |
| 96 | Coronal craniosynostosis (HP:0004440) | 2.17570185 |
| 97 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.17525527 |
| 98 | Lower limb muscle weakness (HP:0007340) | 2.16221015 |
| 99 | Loss of speech (HP:0002371) | 2.15675027 |
| 100 | Distal lower limb muscle weakness (HP:0009053) | 2.15456083 |
| 101 | Seborrheic dermatitis (HP:0001051) | 2.14638177 |
| 102 | Metabolic alkalosis (HP:0200114) | 2.11865542 |
| 103 | Decreased motor nerve conduction velocity (HP:0003431) | 2.11294780 |
| 104 | Popliteal pterygium (HP:0009756) | 2.10797938 |
| 105 | Hypoplastic pelvis (HP:0008839) | 2.10683179 |
| 106 | Acute necrotizing encephalopathy (HP:0006965) | 2.09645620 |
| 107 | Short nail (HP:0001799) | 2.07728349 |
| 108 | Ulnar claw (HP:0001178) | 2.06844260 |
| 109 | Autoamputation (HP:0001218) | 2.06220740 |
| 110 | Broad face (HP:0000283) | 2.03978569 |
| 111 | Hepatosplenomegaly (HP:0001433) | 2.03798573 |
| 112 | Abnormality of the foot musculature (HP:0001436) | 2.03422641 |
| 113 | Neuroendocrine neoplasm (HP:0100634) | 2.02993506 |
| 114 | Absent septum pellucidum (HP:0001331) | 2.01550753 |
| 115 | Diminished movement (HP:0002374) | 2.00701053 |
| 116 | Diaphragmatic weakness (HP:0009113) | 2.00340533 |
| 117 | Peripheral demyelination (HP:0011096) | 1.99495080 |
| 118 | Aplasia involving bones of the extremities (HP:0009825) | 1.99492706 |
| 119 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.99492706 |
| 120 | Aplasia of the phalanges of the hand (HP:0009802) | 1.99492706 |
| 121 | Clumsiness (HP:0002312) | 1.98383579 |
| 122 | Ventricular tachycardia (HP:0004756) | 1.98219842 |
| 123 | Esophageal atresia (HP:0002032) | 1.97346964 |
| 124 | Hypokalemic alkalosis (HP:0001949) | 1.96920216 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.96076625 |
| 126 | Hypoplasia of dental enamel (HP:0006297) | 1.95920184 |
| 127 | Type II lissencephaly (HP:0007260) | 1.95793508 |
| 128 | Abnormality of permanent molar morphology (HP:0011071) | 1.95777080 |
| 129 | Abnormality of the dental root (HP:0006486) | 1.95777080 |
| 130 | Taurodontia (HP:0000679) | 1.95777080 |
| 131 | Alacrima (HP:0000522) | 1.95726465 |
| 132 | Apathy (HP:0000741) | 1.95446384 |
| 133 | Neuronal loss in central nervous system (HP:0002529) | 1.94017960 |
| 134 | Lip pit (HP:0100267) | 1.93993554 |
| 135 | Akinesia (HP:0002304) | 1.93906111 |
| 136 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.92847575 |
| 137 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.92383989 |
| 138 | Steppage gait (HP:0003376) | 1.92133284 |
| 139 | Abnormality of the labia majora (HP:0012881) | 1.91236522 |
| 140 | Achilles tendon contracture (HP:0001771) | 1.90837893 |
| 141 | Spastic paraparesis (HP:0002313) | 1.90760093 |
| 142 | Buphthalmos (HP:0000557) | 1.90644932 |
| 143 | Vascular calcification (HP:0004934) | 1.89898534 |
| 144 | Muscle fiber splitting (HP:0003555) | 1.89874273 |
| 145 | Paraparesis (HP:0002385) | 1.86110335 |
| 146 | Postnatal microcephaly (HP:0005484) | 1.85769935 |
| 147 | Urinary incontinence (HP:0000020) | 1.85727078 |
| 148 | Brittle hair (HP:0002299) | 1.84594784 |
| 149 | Difficulty running (HP:0009046) | 1.83379380 |
| 150 | Distal sensory impairment (HP:0002936) | 1.80096472 |
| 151 | Hyperacusis (HP:0010780) | 1.79626983 |
| 152 | Anomalous pulmonary venous return (HP:0010772) | 1.79188485 |
| 153 | Postural tremor (HP:0002174) | 1.78628601 |
| 154 | Sparse scalp hair (HP:0002209) | 1.78444444 |
| 155 | Fragile nails (HP:0001808) | 1.78145785 |
| 156 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.77253631 |
| 157 | Aplasia cutis congenita (HP:0001057) | 1.75784262 |
| 158 | Abnormality of oral frenula (HP:0000190) | 1.75363188 |
| 159 | Diminished motivation (HP:0000745) | 1.75172719 |
| 160 | Advanced eruption of teeth (HP:0006288) | 1.74888569 |
| 161 | Abnormality of the Achilles tendon (HP:0005109) | 1.74015770 |
| 162 | Abnormality of molar (HP:0011077) | 1.74001979 |
| 163 | Abnormality of molar morphology (HP:0011070) | 1.74001979 |
| 164 | Bowel incontinence (HP:0002607) | 1.73807756 |
| 165 | Patchy hypopigmentation of hair (HP:0011365) | 1.73772475 |
| 166 | Hyperlipoproteinemia (HP:0010980) | 1.72636585 |
| 167 | Fragile skin (HP:0001030) | 1.72108825 |
| 168 | Abnormality of the axillary hair (HP:0100134) | 1.72008904 |
| 169 | Abnormality of secondary sexual hair (HP:0009888) | 1.72008904 |
| 170 | Progressive macrocephaly (HP:0004481) | 1.71517263 |
| 171 | Megalencephaly (HP:0001355) | 1.70552997 |
| 172 | Choreoathetosis (HP:0001266) | 1.70121907 |
| 173 | Myokymia (HP:0002411) | 1.69851271 |
| 174 | Abnormality of the septum pellucidum (HP:0007375) | 1.69735441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 7.98360679 |
| 2 | STK39 | 6.33259999 |
| 3 | MST1R | 6.01420966 |
| 4 | MAPKAPK5 | 5.61296734 |
| 5 | EPHB1 | 5.13014074 |
| 6 | PBK | 3.60486083 |
| 7 | MAP3K12 | 3.35061307 |
| 8 | OXSR1 | 3.13154501 |
| 9 | WNK4 | 3.00729272 |
| 10 | LMTK2 | 2.60511293 |
| 11 | TESK2 | 2.41453524 |
| 12 | PKN1 | 2.39301694 |
| 13 | IRAK3 | 2.36188548 |
| 14 | SIK1 | 2.24636136 |
| 15 | FGFR2 | 2.23114527 |
| 16 | UHMK1 | 2.14616146 |
| 17 | PAK4 | 2.11978524 |
| 18 | MAP3K9 | 2.10776026 |
| 19 | MST4 | 1.99969546 |
| 20 | NME1 | 1.98178833 |
| 21 | PTK2 | 1.97542367 |
| 22 | WNK1 | 1.88376031 |
| 23 | MKNK1 | 1.87199238 |
| 24 | BCR | 1.86559690 |
| 25 | LATS2 | 1.82357279 |
| 26 | SGK223 | 1.81963446 |
| 27 | SGK494 | 1.81963446 |
| 28 | MET | 1.81663940 |
| 29 | MAP3K3 | 1.64952534 |
| 30 | CLK1 | 1.53736259 |
| 31 | LIMK1 | 1.51019784 |
| 32 | NME2 | 1.49380680 |
| 33 | PNCK | 1.48867935 |
| 34 | TESK1 | 1.44275634 |
| 35 | EPHB2 | 1.37174707 |
| 36 | ARAF | 1.34962802 |
| 37 | FGR | 1.30310051 |
| 38 | CAMK2B | 1.29819595 |
| 39 | RPS6KA5 | 1.26427301 |
| 40 | DYRK2 | 1.25614930 |
| 41 | ROCK2 | 1.23405573 |
| 42 | NTRK1 | 1.21628549 |
| 43 | PRKD1 | 1.20800001 |
| 44 | EIF2AK1 | 1.19891945 |
| 45 | CSNK1G3 | 1.19139644 |
| 46 | CSNK1A1L | 1.14901302 |
| 47 | GRK7 | 1.14298853 |
| 48 | EPHA4 | 1.12771744 |
| 49 | LATS1 | 1.12178661 |
| 50 | RPS6KB2 | 1.11977430 |
| 51 | MARK2 | 1.11711099 |
| 52 | SMG1 | 1.11637534 |
| 53 | FLT3 | 1.10034086 |
| 54 | DAPK1 | 1.06798019 |
| 55 | STK38 | 1.05659165 |
| 56 | CAMK2D | 1.05612459 |
| 57 | MYLK | 1.02106681 |
| 58 | CDK8 | 0.99056683 |
| 59 | ABL2 | 0.95975712 |
| 60 | PRKD3 | 0.95138083 |
| 61 | IRAK2 | 0.94855595 |
| 62 | RIPK1 | 0.92325001 |
| 63 | CASK | 0.90253861 |
| 64 | ILK | 0.87279214 |
| 65 | CSNK1G1 | 0.87046720 |
| 66 | SCYL2 | 0.87033017 |
| 67 | NTRK3 | 0.86866900 |
| 68 | GSK3A | 0.86027505 |
| 69 | MAP2K2 | 0.83723403 |
| 70 | CAMK2G | 0.80471365 |
| 71 | MARK1 | 0.79846479 |
| 72 | EPHA3 | 0.79501981 |
| 73 | CAMK2A | 0.79474851 |
| 74 | PRKCE | 0.78272931 |
| 75 | CSNK1G2 | 0.77308114 |
| 76 | BRSK1 | 0.76818446 |
| 77 | TYRO3 | 0.73080041 |
| 78 | DDR2 | 0.70543641 |
| 79 | PRKCQ | 0.69979175 |
| 80 | PAK6 | 0.68774628 |
| 81 | PDGFRA | 0.67650319 |
| 82 | PRKCI | 0.67288366 |
| 83 | MAP3K1 | 0.66683221 |
| 84 | ADRBK2 | 0.65535501 |
| 85 | MINK1 | 0.64978818 |
| 86 | SIK3 | 0.64871514 |
| 87 | CDK14 | 0.62925137 |
| 88 | MAPK15 | 0.61516077 |
| 89 | KSR1 | 0.61322748 |
| 90 | MAP3K2 | 0.59063392 |
| 91 | NTRK2 | 0.57939248 |
| 92 | BLK | 0.57893982 |
| 93 | CDK19 | 0.57716291 |
| 94 | CDK5 | 0.57569029 |
| 95 | PINK1 | 0.56563087 |
| 96 | MAP2K6 | 0.55588931 |
| 97 | CDK15 | 0.55238476 |
| 98 | CDK9 | 0.54675385 |
| 99 | MAPK4 | 0.54063920 |
| 100 | BMPR1B | 0.52920937 |
| 101 | PRKG2 | 0.50628783 |
| 102 | MAPK12 | 0.50521177 |
| 103 | PHKG1 | 0.50093787 |
| 104 | PHKG2 | 0.50093787 |
| 105 | ERN1 | 0.50044434 |
| 106 | CDK18 | 0.49414297 |
| 107 | PAK3 | 0.48173985 |
| 108 | FYN | 0.48154635 |
| 109 | MAPKAPK2 | 0.47787574 |
| 110 | PRKG1 | 0.47374140 |
| 111 | BUB1 | 0.46765967 |
| 112 | CDK11A | 0.46622426 |
| 113 | CSNK1D | 0.45274250 |
| 114 | NEK6 | 0.44879655 |
| 115 | PRKACB | 0.43384540 |
| 116 | FER | 0.42890491 |
| 117 | PDPK1 | 0.41383477 |
| 118 | ICK | 0.41355864 |
| 119 | STK38L | 0.41099574 |
| 120 | CSNK1A1 | 0.41004839 |
| 121 | MUSK | 0.40577014 |
| 122 | GRK5 | 0.40289185 |
| 123 | CAMK1G | 0.39737027 |
| 124 | MAP2K1 | 0.39425627 |
| 125 | BMX | 0.39061220 |
| 126 | AURKB | 0.37193551 |
| 127 | VRK2 | 0.36137982 |
| 128 | NEK1 | 0.35779277 |
| 129 | OBSCN | 0.35552842 |
| 130 | MAPK13 | 0.34587829 |
| 131 | PTK6 | 0.33626974 |
| 132 | PLK2 | 0.33095677 |
| 133 | MAP3K8 | 0.32955934 |
| 134 | PRKACA | 0.32613052 |
| 135 | MELK | 0.32495311 |
| 136 | IRAK1 | 0.31870095 |
| 137 | PIK3CA | 0.31860342 |
| 138 | HIPK2 | 0.30555840 |
| 139 | KSR2 | 0.29996631 |
| 140 | GRK1 | 0.29419927 |
| 141 | ERBB2 | 0.29389591 |
| 142 | PRKD2 | 0.29260857 |
| 143 | AURKA | 0.28497097 |
| 144 | CAMK1 | 0.26721485 |
| 145 | ERBB4 | 0.25415069 |
| 146 | PAK2 | 0.25283499 |
| 147 | STK11 | 0.25162797 |
| 148 | INSR | 0.24467971 |
| 149 | SRC | 0.24116062 |
| 150 | DMPK | 0.23592937 |
| 151 | PAK1 | 0.23405587 |
| 152 | PRKCA | 0.23142215 |
| 153 | RET | 0.22434441 |
| 154 | DYRK1A | 0.22129179 |
| 155 | RAF1 | 0.21921286 |
| 156 | BCKDK | 0.21632797 |
| 157 | RPS6KA4 | 0.21551041 |
| 158 | DAPK3 | 0.21481307 |
| 159 | TIE1 | 0.21387140 |
| 160 | TTK | 0.19604395 |
| 161 | CDK7 | 0.19283124 |
| 162 | EIF2AK2 | 0.18651951 |
| 163 | ZAP70 | 0.18627613 |
| 164 | CDK12 | 0.17673705 |
| 165 | BRAF | 0.17669393 |
| 166 | STK10 | 0.17664948 |
| 167 | LRRK2 | 0.16164959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 6.45325120 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 5.74057631 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 5.45198162 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.42285178 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.71565210 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.43559686 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.32910810 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.31092336 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.23478858 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.17448301 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14968772 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.08088724 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.02431716 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98034219 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 1.91746022 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.89378174 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.88277727 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.83548135 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.83445492 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.82861546 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.80571708 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.79499883 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.57896176 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56240406 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.50429842 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.47658096 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37252811 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.36975476 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34413514 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32278805 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.31390385 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.28692591 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28017598 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27464589 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24921112 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20636814 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19423466 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19144259 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16415936 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 1.15647909 |
| 41 | DNA replication_Homo sapiens_hsa03030 | 1.15414603 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11469906 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 1.09061018 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.07086509 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.05201242 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04862970 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04637699 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03922688 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01831490 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97855190 |
| 51 | Glioma_Homo sapiens_hsa05214 | 0.95686327 |
| 52 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.93068097 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90281240 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89941724 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87515238 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86446547 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86106088 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85631460 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.85601586 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84403320 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82756341 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82596269 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.82530688 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82514885 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82165180 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81537177 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79649856 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78774409 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.77472774 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76980157 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76438801 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.75308043 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74423345 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73726374 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73670254 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73608193 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.73168860 |
| 78 | Base excision repair_Homo sapiens_hsa03410 | 0.71898125 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.71669562 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70002233 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69753856 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69729089 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69363425 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.65789717 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65674198 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.64542997 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64417823 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64362353 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63847246 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62505061 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.62210802 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62177368 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61807556 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.60537575 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.55341485 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.55332245 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55212705 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55151828 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54570082 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.54153136 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.53624953 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53590728 |
| 103 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52911833 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52350824 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51276666 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50935513 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.50816070 |
| 108 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50678007 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50231348 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49725889 |
| 111 | Cell cycle_Homo sapiens_hsa04110 | 0.49532753 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49446245 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49277633 |
| 114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49248006 |
| 115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49224819 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49159581 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49052922 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48775245 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48754429 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47966092 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46963850 |
| 122 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45789787 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.44483427 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42236142 |
| 125 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42223813 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41787588 |
| 127 | Morphine addiction_Homo sapiens_hsa05032 | 0.41529399 |
| 128 | Circadian entrainment_Homo sapiens_hsa04713 | 0.40782569 |
| 129 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40571555 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.40350848 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39815347 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39359123 |
| 133 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38862961 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38533747 |
| 135 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37948968 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.37777699 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37667269 |
| 138 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36798911 |
| 139 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35780428 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35277090 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33383750 |
| 142 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33164011 |
| 143 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32382301 |
| 144 | Salivary secretion_Homo sapiens_hsa04970 | 0.31669335 |
| 145 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31197070 |
| 146 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30775172 |
| 147 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30183980 |
| 148 | ABC transporters_Homo sapiens_hsa02010 | 0.28880269 |
| 149 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27513924 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26979625 |
| 151 | Prion diseases_Homo sapiens_hsa05020 | 0.26933425 |
| 152 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26906546 |
| 153 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26378036 |
| 154 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25801307 |
| 155 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25354107 |
| 156 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24548055 |
| 157 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23978160 |
| 158 | Gap junction_Homo sapiens_hsa04540 | 0.23738099 |
| 159 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22863417 |
| 160 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.20040468 |
| 161 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.18447347 |
| 162 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.17789105 |
| 163 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.16590380 |

